Diabetic retinopathy is the leading cause of preventable blindness in the United States in people 20 to 65 years of age. The standard approach to diabetic retinal exams (DREs) focuses on referring patients with diabetes to an eye specialist, leaving 50 percent of them unexamined each year. The key IRIS benchmarks include: Patients examined: 118,518 Pathology was identified: 55,177 patients Patients found to have mild to moderate disease that could easily progress: 43,588 Patients that have been saved from potential blindness: 11,589 At current rates, one in three Americans with diabetes will have diabetic retinopathy by 2050. Early detection can reduce the risk of severe vision loss by 90 percent, and can significantly reduce long-term healthcare costs. IRIS’ FDA-cleared, telemedicine service improves quality of care by providing access to digital retinal exams in primary care offices which enables physicians to close a care gap for patients with diabetes and be in compliance with a critical Healthcare Effectiveness Data and Information Set (HEDIS) requirement. “We are proud of the partnerships we’ve established with primary care physicians to reach this milestone, but we’re just getting started. Thirty million Americans have diabetes, and half of them go unexamined. If IRIS can provide retinal exams quickly and inexpensively to more patients while making the primary physician’s job easier, everyone wins,” said IRIS CEO Jason Crawford. “Over the last two years, we have seen an astonishing demand for the IRIS solution. Our Company’s growth has tripled and I see that trend continuing in 2017. As a result, we will be doubling our workforce, which will enable us to meet the demand for our technology and provide access for more patients to be examined.” Many IRIS clients, which include major health systems and physician group practices, have successfully integrated the IRIS diabetic retinopathy diagnostic solution with their electronic health records.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/iris-technology-passes-100-000th-144500222.html
A.ew class of drugs has recently become available to treat macular oenema and they are often used in conjunction with the laser therapy. Proliferative diabetic retinopathy PDP. Diabetic retinopathy — Specific treatment for diabetic retinopathy depends on the nature of the problem: Proliferative disease and swelling or leaking of the retina can be treated with laser therapy. A surgical procedure called a vitrectomy can be used to remove the blood that has leaked into this part of the eye. It’s unusual for hypertension to impair vision, but hypertensive retinopathy can lead to blockage of retinal arteries or veins, which in turn may eventually result in the loss of vision. New blood vessels grow on the retina. http://www.chinadragontour.com/mearianacruz/2016/11/04/professional-tips-for-selecting-necessary-elements-of-astigmatism/Trauma, especially to the head, and several diseases may cause Purtscher’s retinopathy Hyperviscosity-related retinopathy as seen in disorders which cause paraproteinemia Many types of retinopathy are proliferative, most often resulting from neovascularization or blood vessel overgrowth. Diabetic and hypertensive retinopathy are diagnosed in much the same way. Macula edema is noted when areas of your retina are shown to contain spaces filled with fluid. Treatment can start before sight is affected, which helps prevent vision loss. An ophthalmologist should monitor you closely for three to six months. The spreading of a syphilis infection to the retinal blood vessels causes syphilitic retinopathy, and diabetes damages the retinal vessels resulting in a condition called diabetic retinopathy .
Progress.n Retinal and Eye Research. 2014;41:26. Some use drugs to reduce pressure in the eye, while others involve surgery. Robertson D expert opinion. http://www.malleyandco.com/advisingeyedoc/2016/11/01/an-inside-look-at-finding-indispensable-issues-in-glaucoma/This stimulates the growth of new blood vessels to replace the blocked ones. The macula is a very small area at the canter of the retina. This is called a retinal detachment . Other trials have shown that controlling elevated blood pressure and cholesterol can reduce the risk of vision loss among people with diabetes. This results in blurred vision or poor night vision.